Description

The global lactose intolerance treatment market is poised to grow by US$ 9.7 billion during 2022-2028, progressing at a CAGR of 5.5% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for lactose intolerance treatment. The global lactose intolerance treatment market is segmented on the basis of cause, treatment, form, end user, and region. By cause, the global lactose intolerance treatment market has been segmented into congenital lactose deficiency, primary lactose deficiency, secondary lactose deficiency. Based upon treatment, the global lactose intolerance treatment market is categorized into food supplements, lactase enzyme supplements, probiotics, others. On the basis of form, the global lactose intolerance treatment market has been segmented into liquid, powder, tablets/capsules. By end user, the global lactose intolerance treatment market has been segmented into home care, hospitals & clinics. Geographically, the global lactose intolerance treatment market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global lactose intolerance treatment market is highly competitive. The prominent players operating in the global lactose intolerance treatment market include Abbott Laboratories, Arla Foods amba, Cargill Incorporated, Dairy Farmers of America Inc., Deerland Enzymes Inc., Guardian Drug Company, Johnson & Johnson, Nestle S.A., Novozymes A/S, Ritter Pharmaceuticals Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the lactose intolerance treatment market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Cause: congenital lactose deficiency, primary lactose deficiency, secondary lactose deficiency
Treatment: food supplements, lactase enzyme supplements, probiotics, others
Form: liquid, powder, tablets/capsules
End user: home care, hospitals & clinics
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global lactose intolerance treatment market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Lactose intolerance treatment market overview
Part 3. Market breakdown by cause
– Congenital lactose deficiency
– Primary lactose deficiency
– Secondary lactose deficiency
Part 4. Market breakdown by treatment
– Food supplements
– Lactase enzyme supplements
– Probiotics
– Others
Part 5. Market breakdown by form
– Liquid
– Powder
– Tablets/capsules
Part 6. Market breakdown by end user
– Home care
– Hospitals & clinics
Part 7. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 8. Key companies
– Abbott Laboratories
– Arla Foods amba
– Cargill, Incorporated
– Dairy Farmers of America, Inc.
– Deerland Enzymes, Inc.
– Guardian Drug Company
– Johnson & Johnson
– Nestle S.A.
– Novozymes A/S
– Ritter Pharmaceuticals, Inc.
About StrategyHelix
Disclaimer